NDC 0025-1021

ALDACTAZIDE

Spironolactone And Hydrochlorothiazide

ALDACTAZIDE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by G.d. Searle Llc Division Of Pfizer Inc. The primary component is Spironolactone; Hydrochlorothiazide.

Product ID0025-1021_21efa415-8c89-4298-961d-2b3ec11ed531
NDC0025-1021
Product TypeHuman Prescription Drug
Proprietary NameALDACTAZIDE
Generic NameSpironolactone And Hydrochlorothiazide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1978-01-01
Marketing CategoryNDA / NDA
Application NumberNDA012616
Labeler NameG.D. Searle LLC Division of Pfizer Inc
Substance NameSPIRONOLACTONE; HYDROCHLOROTHIAZIDE
Active Ingredient Strength50 mg/1; mg/1
Pharm ClassesAldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0025-1021-31

100 TABLET, FILM COATED in 1 BOTTLE (0025-1021-31)
Marketing Start Date1978-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0025-1021-31 [00025102131]

ALDACTAZIDE TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA012616
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1978-01-01

Drug Details

Active Ingredients

IngredientStrength
SPIRONOLACTONE50 mg/1

OpenFDA Data

SPL SET ID:d44637a7-b980-4bb1-832c-f5a0f73f8259
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 208112
  • 208116
  • 198224
  • 198225
  • UPC Code
  • 0300251011313
  • Pharmacological Class

    • Aldosterone Antagonist [EPC]
    • Aldosterone Antagonists [MoA]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]
    • Aldosterone Antagonist [EPC]
    • Aldosterone Antagonists [MoA]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "ALDACTAZIDE" or generic name "Spironolactone And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0025-1011ALDACTAZIDEspironolactone and hydrochlorothiazide
    0025-1021ALDACTAZIDEspironolactone and hydrochlorothiazide
    0378-0141Spironolactone and Hydrochlorothiazidespironolactone and hydrochlorothiazide
    0378-0403Spironolactone and Hydrochlorothiazidespironolactone and hydrochlorothiazide
    42292-017Spironolactone and Hydrochlorothiazidespironolactone and hydrochlorothiazide
    53489-144Spironolactone and HydrochlorothiazideSpironolactone and Hydrochlorothiazide
    59762-5014Spironolactone and Hydrochlorothiazidespironolactone and hydrochlorothiazide
    63629-1068Spironolactone and HydrochlorothiazideSpironolactone and Hydrochlorothiazide
    63629-1069Spironolactone and HydrochlorothiazideSpironolactone and Hydrochlorothiazide
    63629-1071Spironolactone and HydrochlorothiazideSpironolactone and Hydrochlorothiazide
    66993-188Spironolactone and Hydrochlorothiazidespironolactone and hydrochlorothiazide

    Trademark Results [ALDACTAZIDE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ALDACTAZIDE
    ALDACTAZIDE
    72093367 0706217 Live/Registered
    G. D. Searle & Co.
    1960-03-21

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.